Pfizer beat third-quarter expectations and raised its 2021 forecast again even as sales of its top product, the COVID-19 vaccine Comirnaty, slipped in the U.S. Soaring international sales of the preventive shots helped pushed total Comirnaty revenue close to $13 billion in the quarter, and the drugmaker said Tuesday that it now expects to book about $36 billion in sales from the vaccine this year
Related posts
-
Auto group adds two new electric vehicle dealerships in Lisle
Chicagoland Auto Group is adding two new electric vehicle dealerships in Lisle. VinFast opened Saturday and... -
‘A matter of our survival:’ Naperville restaurant owners ask city to reconsider gambling ban
Naperville restaurant owners say video gaming could provide a much needed lifeline as they struggle with... -
How a new program will keep hard-to-recycle items out of landfills
A new program arriving next month in several Lake County communities and townships targets hard-to-recycle items...